- Home
- UPXI vs INMB Comparison
UPXI vs INMB Comparison
Compare UPXI & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UPXI | INMB |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.8M | 64.7M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | UPXI | INMB |
|---|---|---|
| Price | $1.03 | $2.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $2.00 | ★ $5.40 |
| AVG Volume (30 Days) | ★ 3.5M | 307.9K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.49 | 11.85 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,811,345.00 | $50,000.00 |
| Revenue This Year | $118.99 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $0.54 | $1.09 |
| 52 Week High | $7.75 | $2.60 |
Technical Indicators
Market Signals| Indicator | UPXI | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 51.84 | 55.16 |
| Support Level | $0.91 | $2.21 |
| Resistance Level | $1.17 | $2.50 |
| Average True Range (ATR) | 0.08 | 0.14 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 19.23 | 32.93 |
Price Performance
Historical ComparisonAbout UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via Solana. Geographically, the company generates the majority of its revenue from the United States.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.